Related Experiment Videos
Tibial bypass using complex autologous conduit: patency and limb salvage
B G Halloran1, M P Lilly, E J Cohn
1Division of Vascular Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Annals of Vascular Surgery
|January 5, 2002
Summary
Complex autologous vein grafts for lower extremity bypasses achieved good limb salvage rates in patients with critical limb ischemia. Regular monitoring and timely revisions significantly improved outcomes, demonstrating the value of these intricate procedures.
Area of Science:
- Vascular Surgery
- Reconstructive Surgery
- Peripheral Artery Disease
Background:
- Limb-threatening ischemia often requires complex surgical interventions.
- Autologous veins are frequently used for lower extremity bypass, but alternatives are needed when ipsilateral great saphenous vein (GSV) is inadequate.
Purpose of the Study:
- To evaluate the long-term outcomes of complex autologous bypass grafts for limb salvage in patients with severe lower extremity ischemia.
- To assess graft patency, survival, and limb salvage rates associated with various autologous conduits.
Main Methods:
- A retrospective review of 93 lower extremity bypasses using diverse autologous conduits over 8 years.
- Life-table analysis was employed to examine survival, patency, and limb salvage rates.
- Graft revisions for stenosis or thrombosis were analyzed for their impact on limb salvage.
Main Results:
- Five-year primary, assisted-primary, and secondary graft patency rates were 38%, 59%, and 64%, respectively.
- Overall 5-year limb salvage rate was 73%.
- Limb salvage was significantly better when revisions addressed graft stenosis (90%) compared to thrombosis (46%).
Conclusions:
- Complex autologous tibial bypasses offer acceptable long-term limb salvage for severe ischemia when ipsilateral GSV is unavailable.
- Postoperative surveillance and timely graft revision are crucial for improving limb salvage.
- These complex procedures, despite increased operative time, do not pose prohibitive risks.